CSL Seqirus inks bird flu vaccine supply pact with UK after similar deals in US, Europe
December 3, 2024Coherus sells its last biosimilar Udenyca to Intas for up to $558M as company homes in on novel cancer meds
December 3, 2024IRA price negotiations and M&A among topics to watch after Republican ‘red wave,’ analyst group says
fkansteiner
Tue, 12/03/2024 – 14:03
